United States Biotechnology & Medical Research

Galectin Therapeutics Inc (GALT)

Track

Track

Galectin Therapeutics experienced eleven insider trading transactions over the past ninety days, totaling over one million dollars in sales. These divestments involved key personnel, including the Chief Medical Officer. Despite a thirty-nine percent stock price increase recently, the firm reported a significant miss in its latest earnings report.
Ticker: GALT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Galectin Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
95.02
Quantity 47,887 -33.9%
Value US$3,808,770
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
418.07
Quantity 19,874 -18.7%
Value US$4,014,068
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
126.79
Quantity 52,256 +23.5%
Value US$3,365,202
2.9
Harold Shlevin Director Non-Executive Director
Transaction date
Proposed sale
Price
5.04
Quantity 22,268
Value US$112,212
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
5.00
Quantity 7,732 -54.3%
Value US$38,660
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.00
Quantity 2,533 -100.0%
Value US$12,665
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.00
Quantity 2,037 -100.0%
Value US$10,185
Jamil Khurram Officer Officer
Transaction date
Proposed sale
Price
5.00
Quantity 68,287
Value US$341,435
2.9
HAROLD SHLEVIN DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
5.00
Quantity 7,732
Value US$38,680
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
3.14
Quantity 7,557 -100.0%
Value US$23,729
Jamil Khurram Officer Officer
Transaction date
Proposed sale
Price
3.14
Quantity 8,125
Value US$25,500
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
3.10
Quantity 568 -100.0%
Value US$1,761
4.1
ELDRED KARY Non-Executive Director
Transaction date
Purchase
Price
2.70
Quantity 300 +0.5%
Value US$810
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
3.65
Quantity 21,446 -100.0%
Value US$78,205
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.67
Quantity 20,354 -72.8%
Value US$74,695
2.3
LEWIS JOEL President and CEO Executive Director
Transaction date
Planned sale
Price
3.58
Quantity 37,698 -4.3%
Value US$134,853
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
3.90
Quantity 25,499 -54.3%
Value US$99,408
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.90
Quantity 25,732 -47.9%
Value US$100,298
2.3
LEWIS JOEL President and CEO Executive Director
Transaction date
Planned sale
Price
3.91
Quantity 27,731 -3.1%
Value US$108,342
2.9
Shlevin Harold H. Director Non-Executive Director
Transaction date
Proposed sale
Price
4.16
Quantity 441,500
Value US$1,836,640
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.20
Quantity 13,055 -21.8%
Value US$54,789
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
4.20
Quantity 13,914 -20.6%
Value US$58,394
2.3
LEWIS JOEL President and CEO Executive Director
Transaction date
Planned sale
Price
4.20
Quantity 18,571 -2.0%
Value US$77,939
2.3
CALLICUTT JACK W Officer Officer
Transaction date
Proposed sale
Price
4.20
Quantity 60,000
Value US$252,000
2.3
LEWIS JOEL Officer Officer
Transaction date
Proposed sale
Price
4.20
Quantity 84,000
Value US$352,800
Jamil Khurram Officer Officer
Transaction date
Proposed sale
Price
4.20
Quantity 60,000
Value US$252,000
2.3
CALLICUTT JACK W Officer Officer
Transaction date
Proposed sale
Price
4.20
Quantity 141,206
Value US$593,065
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.07
Quantity 8,125 -100.0%
Value US$33,089
4.1
ELDRED KARY Non-Executive Director
Transaction date
Purchase
Price
3.73
Quantity 700 +1.1%
Value US$2,611
3.2
FREEMAN KEVIN D Non-Executive Director
Transaction date
Purchase
Price
3.55
Quantity 5,500 +11.1%
Value US$19,514
4.1
ELDRED KARY Non-Executive Director
Transaction date
Purchase
Price
3.73
Quantity 700 +1.1%
Value US$2,611
2.3
LEWIS JOEL President and CEO Executive Director
Transaction date
Planned sale
Price
7.06
Quantity 7,829 -0.9%
Value US$55,241
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
7.04
Quantity 4,706 -42.0%
Value US$33,121
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
7.04
Quantity 19,793 -63.9%
Value US$139,303
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.04
Quantity 8,500 -100.0%
Value US$59,840
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.04
Quantity 6,463 -100.0%
Value US$45,500
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.04
Quantity 4,479 -100.0%
Value US$31,532
Jamil Khurram Officer Officer
Transaction date
Proposed sale
Price
7.04
Quantity 21,479
Value US$151,212
2.3
LEWIS JOEL Officer Officer
Transaction date
Proposed sale
Price
7.06
Quantity 40,000
Value US$282,244
2.9
HAROLD SHLEVIN DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
6.97
Quantity 24,706
Value US$172,223
4.3
10X Fund, L.P. Large shareholder
Transaction date
Sale
Price
6.66
Quantity 30,681 -0.5%
Value US$204,335
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
6.30
Quantity 8,417 -42.9%
Value US$53,027
2.9
HAROLD SHLEVIN DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
6.24
Quantity 8,417
Value US$52,542
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
6.27
Quantity 19,793 -63.9%
Value US$124,181
2.9
HAROLD SHLEVIN DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
6.21
Quantity 19,793
Value US$122,993
2.9
HAROLD SHLEVIN DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
6.21
Quantity 19,793
Value US$122,993
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
6.27
Quantity 16,790 -60.0%
Value US$105,206
2.9
HAROLD SHLEVIN DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
6.21
Quantity 16,790
Value US$104,198
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
6.00
Quantity 20,000 -64.1%
Value US$120,040
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
6.02
Quantity 35,000 -75.7%
Value US$210,665
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
5.95
Quantity 25,000 -69.0%
Value US$148,650
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
5.96
Quantity 20,000 -64.1%
Value US$119,240
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
5.96
Quantity 20,000 -64.1%
Value US$119,240
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
5.95
Quantity 35,000 -75.7%
Value US$208,250
2.9
Shlevin Harold H. Non-Executive Director
Transaction date
Planned sale
Price
6.01
Quantity 4,000 -26.3%
Value US$24,020
2.9
HAROLD SHLEVIN DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
6.02
Quantity 159,000
Value US$957,180
4.3
10X Fund, L.P. Large shareholder
Transaction date
Sale
Price
5.73
Quantity 120,000 -2.1%
Value US$687,600
4.3
10X Fund, L.P. Large shareholder
Transaction date
Sale
Price
5.47
Quantity 30,000 -0.5%
Value US$164,100
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.22
Quantity 18,210 -70.5%
Value US$113,321
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.22
Quantity 28,100 -78.7%
Value US$174,866
2.3
LEWIS JOEL President and CEO Executive Director
Transaction date
Planned sale
Price
6.15
Quantity 6,783 -0.8%
Value US$41,723
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.03
Quantity 2,323 -23.4%
Value US$14,012
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.03
Quantity 19,701 -72.1%
Value US$118,831
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.03
Quantity 9,586 -55.7%
Value US$57,820
2.3
LEWIS JOEL President and CEO Executive Director
Transaction date
Planned sale
Price
6.04
Quantity 15,680 -1.8%
Value US$94,643
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.47
Quantity 16,250 -78.4%
Value US$88,888
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.47
Quantity 41,500 -90.3%
Value US$227,005
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.47
Quantity 41,500 -90.3%
Value US$227,005
Jamil Khurram Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.47
Quantity 21,867 -83.0%
Value US$119,612
Jamil Khurram Officer Officer
Transaction date
Proposed sale
Price
5.45
Quantity 121,117
Value US$660,088
4.3
10X Fund, L.P. Large shareholder
Transaction date
Sale
Price
5.25
Quantity 40,000 -0.7%
Value US$210,000
2.3
LEWIS JOEL President and CEO Executive Director
Transaction date
Planned sale
Price
6.03
Quantity 1,867 -0.2%
Value US$11,252
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.03
Quantity 1,736 -18.6%
Value US$10,468
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.03
Quantity 1,675 -18.0%
Value US$10,095
2.3
CALLICUTT JACK W Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.02
Quantity 1,880 -19.8%
Value US$11,321
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-14 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
47,887 -33.9%
95.02
US$3,808,770 		47,887 -33.9% 95.02 US$3,808,770
2026-06-30 2026-06-29 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
19,874 -18.7%
418.07
US$4,014,068 		19,874 -18.7% 418.07 US$4,014,068
2026-06-30 2026-06-29 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
52,256 +23.5%
126.79
US$3,365,202 		52,256 +23.5% 126.79 US$3,365,202
2026-06-29 2026-06-29 PrS Proposed sale
2.9
Harold Shlevin

Director

Non-Executive Director
22,268
5.04
US$112,212 		22,268 5.04 US$112,212
2026-06-30 2026-06-26 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
7,732 -54.3%
5.00
US$38,660 		7,732 -54.3% 5.00 US$38,660
2026-06-30 2026-06-26 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
2,533 -100.0%
5.00
US$12,665 		2,533 -100.0% 5.00 US$12,665
2026-06-30 2026-06-26 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
2,037 -100.0%
5.00
US$10,185 		2,037 -100.0% 5.00 US$10,185
2026-06-26 2026-06-26 PrS Proposed sale
Jamil Khurram

Officer

Officer
68,287
5.00
US$341,435 		68,287 5.00 US$341,435
2026-06-26 2026-06-26 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
7,732
5.00
US$38,680 		7,732 5.00 US$38,680
2026-06-25 2026-06-23 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
7,557 -100.0%
3.14
US$23,729 		7,557 -100.0% 3.14 US$23,729
2026-06-23 2026-06-23 PrS Proposed sale
Jamil Khurram

Officer

Officer
8,125
3.14
US$25,500 		8,125 3.14 US$25,500
2026-05-28 2026-05-26 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
568 -100.0%
3.10
US$1,761 		568 -100.0% 3.10 US$1,761
2026-02-09 2026-02-06 B Purchase
4.1
ELDRED KARY
Non-Executive Director
300 +0.5%
2.70
US$810 		300 +0.5% 2.70 US$810
2026-01-06 2026-01-06 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
21,446 -100.0%
3.65
US$78,205 		21,446 -100.0% 3.65 US$78,205
2026-01-06 2026-01-06 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
20,354 -72.8%
3.67
US$74,695 		20,354 -72.8% 3.67 US$74,695
2026-01-06 2026-01-06 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
37,698 -4.3%
3.58
US$134,853 		37,698 -4.3% 3.58 US$134,853
2026-01-06 2026-01-05 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
25,499 -54.3%
3.90
US$99,408 		25,499 -54.3% 3.90 US$99,408
2026-01-06 2026-01-05 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
25,732 -47.9%
3.90
US$100,298 		25,732 -47.9% 3.90 US$100,298
2026-01-06 2026-01-05 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
27,731 -3.1%
3.91
US$108,342 		27,731 -3.1% 3.91 US$108,342
2026-01-06 2026-01-02 PrS Proposed sale
2.9
Shlevin Harold H.

Director

Non-Executive Director
441,500
4.16
US$1,836,640 		441,500 4.16 US$1,836,640
2026-01-06 2026-01-02 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
13,055 -21.8%
4.20
US$54,789 		13,055 -21.8% 4.20 US$54,789
2026-01-06 2026-01-02 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
13,914 -20.6%
4.20
US$58,394 		13,914 -20.6% 4.20 US$58,394
2026-01-06 2026-01-02 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
18,571 -2.0%
4.20
US$77,939 		18,571 -2.0% 4.20 US$77,939
2026-01-05 2026-01-02 PrS Proposed sale
2.3
CALLICUTT JACK W

Officer

Officer
60,000
4.20
US$252,000 		60,000 4.20 US$252,000
2026-01-02 2026-01-02 PrS Proposed sale
2.3
LEWIS JOEL

Officer

Officer
84,000
4.20
US$352,800 		84,000 4.20 US$352,800
2026-01-02 2026-01-02 PrS Proposed sale
Jamil Khurram

Officer

Officer
60,000
4.20
US$252,000 		60,000 4.20 US$252,000
2026-01-02 2026-01-02 PrS Proposed sale
2.3
CALLICUTT JACK W

Officer

Officer
141,206
4.20
US$593,065 		141,206 4.20 US$593,065
2026-01-05 2025-12-31 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
8,125 -100.0%
4.07
US$33,089 		8,125 -100.0% 4.07 US$33,089
2025-12-23 2025-12-23 B Purchase
4.1
ELDRED KARY
Non-Executive Director
700 +1.1%
3.73
US$2,611 		700 +1.1% 3.73 US$2,611
2025-12-23 2025-12-23 B Purchase
3.2
FREEMAN KEVIN D
Non-Executive Director
5,500 +11.1%
3.55
US$19,514 		5,500 +11.1% 3.55 US$19,514
2025-12-23 2025-12-23 B Purchase
4.1
ELDRED KARY
Non-Executive Director
700 +1.1%
3.73
US$2,611 		700 +1.1% 3.73 US$2,611
2025-12-19 2025-12-17 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
7,829 -0.9%
7.06
US$55,241 		7,829 -0.9% 7.06 US$55,241
2025-12-19 2025-12-17 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
4,706 -42.0%
7.04
US$33,121 		4,706 -42.0% 7.04 US$33,121
2025-12-19 2025-12-17 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
19,793 -63.9%
7.04
US$139,303 		19,793 -63.9% 7.04 US$139,303
2025-12-19 2025-12-17 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
8,500 -100.0%
7.04
US$59,840 		8,500 -100.0% 7.04 US$59,840
2025-12-19 2025-12-17 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
6,463 -100.0%
7.04
US$45,500 		6,463 -100.0% 7.04 US$45,500
2025-12-19 2025-12-17 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
4,479 -100.0%
7.04
US$31,532 		4,479 -100.0% 7.04 US$31,532
2025-12-17 2025-12-17 PrS Proposed sale
Jamil Khurram

Officer

Officer
21,479
7.04
US$151,212 		21,479 7.04 US$151,212
2025-12-17 2025-12-17 PrS Proposed sale
2.3
LEWIS JOEL

Officer

Officer
40,000
7.06
US$282,244 		40,000 7.06 US$282,244
2025-12-17 2025-12-17 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
24,706
6.97
US$172,223 		24,706 6.97 US$172,223
2025-12-18 2025-12-16 S Sale
4.3
10X Fund, L.P.
Large shareholder
30,681 -0.5%
6.66
US$204,335 		30,681 -0.5% 6.66 US$204,335
2025-12-16 2025-12-15 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
8,417 -42.9%
6.30
US$53,027 		8,417 -42.9% 6.30 US$53,027
2025-12-15 2025-12-15 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
8,417
6.24
US$52,542 		8,417 6.24 US$52,542
2025-12-16 2025-12-12 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
19,793 -63.9%
6.27
US$124,181 		19,793 -63.9% 6.27 US$124,181
2025-12-15 2025-12-12 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
19,793
6.21
US$122,993 		19,793 6.21 US$122,993
2025-12-12 2025-12-12 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
19,793
6.21
US$122,993 		19,793 6.21 US$122,993
2025-12-10 2025-12-09 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
16,790 -60.0%
6.27
US$105,206 		16,790 -60.0% 6.27 US$105,206
2025-12-09 2025-12-09 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
16,790
6.21
US$104,198 		16,790 6.21 US$104,198
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
20,000 -64.1%
6.00
US$120,040 		20,000 -64.1% 6.00 US$120,040
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
35,000 -75.7%
6.02
US$210,665 		35,000 -75.7% 6.02 US$210,665
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
25,000 -69.0%
5.95
US$148,650 		25,000 -69.0% 5.95 US$148,650
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
20,000 -64.1%
5.96
US$119,240 		20,000 -64.1% 5.96 US$119,240
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
20,000 -64.1%
5.96
US$119,240 		20,000 -64.1% 5.96 US$119,240
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
35,000 -75.7%
5.95
US$208,250 		35,000 -75.7% 5.95 US$208,250
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
4,000 -26.3%
6.01
US$24,020 		4,000 -26.3% 6.01 US$24,020
2025-12-08 2025-12-08 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
159,000
6.02
US$957,180 		159,000 6.02 US$957,180
2025-12-04 2025-12-03 S Sale
4.3
10X Fund, L.P.
Large shareholder
120,000 -2.1%
5.73
US$687,600 		120,000 -2.1% 5.73 US$687,600
2025-12-04 2025-12-02 S Sale
4.3
10X Fund, L.P.
Large shareholder
30,000 -0.5%
5.47
US$164,100 		30,000 -0.5% 5.47 US$164,100
2025-11-19 2025-11-18 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
18,210 -70.5%
6.22
US$113,321 		18,210 -70.5% 6.22 US$113,321
2025-11-19 2025-11-18 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
28,100 -78.7%
6.22
US$174,866 		28,100 -78.7% 6.22 US$174,866
2025-11-19 2025-11-18 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
6,783 -0.8%
6.15
US$41,723 		6,783 -0.8% 6.15 US$41,723
2025-11-19 2025-11-17 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
2,323 -23.4%
6.03
US$14,012 		2,323 -23.4% 6.03 US$14,012
2025-11-19 2025-11-17 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
19,701 -72.1%
6.03
US$118,831 		19,701 -72.1% 6.03 US$118,831
2025-11-19 2025-11-17 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
9,586 -55.7%
6.03
US$57,820 		9,586 -55.7% 6.03 US$57,820
2025-11-19 2025-11-17 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
15,680 -1.8%
6.04
US$94,643 		15,680 -1.8% 6.04 US$94,643
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
16,250 -78.4%
5.47
US$88,888 		16,250 -78.4% 5.47 US$88,888
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
41,500 -90.3%
5.47
US$227,005 		41,500 -90.3% 5.47 US$227,005
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
41,500 -90.3%
5.47
US$227,005 		41,500 -90.3% 5.47 US$227,005
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
21,867 -83.0%
5.47
US$119,612 		21,867 -83.0% 5.47 US$119,612
2025-11-13 2025-11-13 PrS Proposed sale
Jamil Khurram

Officer

Officer
121,117
5.45
US$660,088 		121,117 5.45 US$660,088
2025-11-12 2025-11-11 S Sale
4.3
10X Fund, L.P.
Large shareholder
40,000 -0.7%
5.25
US$210,000 		40,000 -0.7% 5.25 US$210,000
2025-11-12 2025-11-10 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
1,867 -0.2%
6.03
US$11,252 		1,867 -0.2% 6.03 US$11,252
2025-11-12 2025-11-10 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,736 -18.6%
6.03
US$10,468 		1,736 -18.6% 6.03 US$10,468
2025-11-12 2025-11-10 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,675 -18.0%
6.03
US$10,095 		1,675 -18.0% 6.03 US$10,095
2025-11-12 2025-11-10 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,880 -19.8%
6.02
US$11,321 		1,880 -19.8% 6.02 US$11,321
Explore more

More insider trading research around Galectin Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America